Investing Ideas
/
Indian Pharmaceuticals & Biotech Too Big To Fail

Indian Pharmaceuticals & Biotech Too Big To Fail

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Large established companies which pay a dividend.

1 companies

Abbott India

Market Cap: ₹540.5b

Operates as a pharmaceutical company in India.

500488

₹25,567.00

-0.1%

-27.8%